Showing 101-110 of 1150 results for "".
The Latest on Systemic Agents for Psoriasis: A Q&A With Jashin J. Wu, MD, FAAD
https://practicaldermatology.com/programs/practical-dermatology-focus-psoriasis/the-latest-on-systemic-agents-for-psoriasis/29073/The pharmacologic pipeline continues to produce strong options for systemic treatment of psoriasis. Practical Dermatology® spoke with Editorial Board member Jashin J. Wu, MD, FAAD, Founder and CEO of the Dermatology Research and Education Foundation, to discuss the latest treatment considerations wiJournal Club: Biologics for Young Children
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/journal-club-biologics-for-young-children/32400/Practical Dermatology Editorial Board member Lawrence Eichenfield, MD, FAAD, Dawn Eichenfield, MD, PhD, discuss the article "Biologic therapies in infants and children younger than 6 years of age with atopic dermatitis: suitability and practical considerations," from Expert Opinion on Drug Safety. RNew Products Therapeutics Focus: Acne
https://practicaldermatology.com/topics/practice-management/new-products-therapeutics-focus-acne/21134/Digital Photomapping (DPM) in Mohs
https://practicaldermatology.com/topics/general-topics/digital-photomapping-dpm-in-mohs/20682/@PRACTICAL_DERM
https://practicaldermatology.com/topics/practice-management/practical_derm/21168/@PRACTICAL_DERM
https://practicaldermatology.com/topics/skin-cancer-photoprotection/practical_derm/21185/Precision Medicine 101
https://practicaldermatology.com/topics/practice-management/precision-medicine-101/20657/New Products and Pharmacologic Developments
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacologic-developments/21460/The Biosimilar Revolution: A Look at the Potential Impact
https://practicaldermatology.com/issues/april-2025/the-biosimilar-revolution-a-look-at-the-potential-impact/35596/With many biosimilars expected to gain regulatory approval in coming months and years, Practical Dermatology interviewed Collin Blattner, DO, FAAD—an editorial board member and double-board–certified dermatologist who owns Clearchoice Dermatology, which has 12 locations in Oregon and Washington—abouAnti-Semitism and Dermatologists
https://practicaldermatology.com/series/editors-message/anti-semitism-and-dermatologists/23988/(A Personal Narrative from the Editor)